For instance, the disruption of the CB1 gene increased, whereas the pharmacologic blockade of the very same receptor by the antagonist SR141716A decreased anxiety; the blockade of the FAAH enzyme did not affect anxiety directly but altered the way in which challenges (e.g., stressors) were responded [241,242]. The gene discussed is CNR1; the disease is Anxiety.